Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Jerry A. Winkelstein(Johns Hopkins University), Howard B. Dickler(National Institutes of Health), Steven J. Chanock, Mary C. Marino(Immune Deficiency Foundation), Hans D. Ochs(Infectious Disease Research Institute), Rebecca H. Buckley(Duke Medical Center), John I. Gallin(National Institute of Allergy and Infectious Diseases), John Boyle(Ocean Institute), John T. Curnutte(Portola Pharmaceuticals (United States)), Richard B. Johnston(World Health Organization), Charles B. Foster(Cleveland Clinic), Paul G. Quie, Harry L. Malech(University of Maryland, Baltimore)
Cited by 1,717
Related Papers
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
|Nature Genetics|2001|3.4k
Burden of disease from inadequate water, sanitation and hygiene for selected adverse health outcomes: An updated analysis with a focus on low- and middle-income countries
|International Journal of Hygiene and Environmental Health|2019|1.2k
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
|New England Journal of Medicine|2015|1k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
|New England Journal of Medicine|2019|945